NexImmune Appoints Healthcare Innovator Grant Verstandig as New Board Member

NEXT STORY
Iovance Biotherapeutics to Present at Upcoming Healthcare Conferences
PREV STORY
XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Letter to Shareholders from Curt Fairbrother CEO, MedTainer Inc.

CORONA, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Dear Shareholders: Tomorrow’s elections signify another ...

author_avatar
NASDAQ Market News

XBiotech berichtet über Entwicklungen im dritten Quartal 2018

Unternehmen stellt aktualisierte Übersicht zur klinischen und Entdeckungs-Pipeline sowie anderen Unternehmensinitiativen vor AUSTIN, Texas, ...

author_avatar
NASDAQ Market News

CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development

author_avatar
NASDAQ Market News